{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:39:48Z","timestamp":1793367588318,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.amjmed.2018.04.025","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T04:44:22Z","timestamp":1525927462000},"page":"1382.e1-1382.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8204-6907","authenticated-orcid":false,"given":"Sameer","family":"Hassamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Miotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itai","family":"Danovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2018.04.025_bib0001","first-page":"17","article-title":"Tramadol: seizures, serotonin syndrome, and coadministered antidepressants","volume":"6","author":"Sansone","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0002","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/SMJ.0b013e3181616e66","article-title":"Similar effects of tramadol and venlafaxine in major depressive disorder","volume":"101","author":"Reeves","year":"2008","journal-title":"South Med J"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0003","first-page":"717","article-title":"The role of tramadol in current treatment strategies for musculoskeletal pain","volume":"3","author":"Schug","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0004","article-title":"Tramadol for neuropathic pain in adults","volume":"6","author":"Duehmke","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0005","first-page":"543","article-title":"Tramadol for osteoarthritis: a systematic review and metaanalysis","volume":"34","author":"Cepeda","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0006","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.urology.2011.09.031","article-title":"On-demand tramadol hydrochloride use in premature ejaculation treatment","volume":"79","author":"Kaynar","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0007","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0310057X0102900209","article-title":"Tramadol for postoperative shivering: a double-blind comparison with pethidine","volume":"29","author":"Bhatnagar","year":"2001","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0008","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.v62n0312b","article-title":"Treatment of refractory major depression with tramadol monotherapy","volume":"62","author":"Shapira","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0009","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1300\/J069v22n04_02","article-title":"Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study","volume":"22","author":"Tamaskar","year":"2003","journal-title":"J Addict Dis"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0010","unstructured":"Agency Medical Directors' Group. Opioid Dose Calculator. http:\/\/www.agencymeddirectors.wa.gov\/calculator\/dosecalculator.htm. 2015."},{"key":"10.1016\/j.amjmed.2018.04.025_bib0011","first-page":"395","article-title":"Tramadol, pharmacology, side effects, and serotonin syndrome: a review","volume":"18","author":"Beakley","year":"2015","journal-title":"Pain Physician"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0012","unstructured":"Food and Drug Administration. FDA Adverse Event Report System.https:\/\/fis.fda.gov\/sense\/app\/777e9f4d-0cf8-448e-8068-f564c31baa25\/sheet\/7a47a261-d58b-4203-a8aa-6d3021737452\/state\/analysis. 2018."},{"key":"10.1016\/j.amjmed.2018.04.025_bib0013","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"New Engl J Med"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0014","first-page":"988","article-title":"Recognition and treatment of serotonin syndrome","volume":"54","author":"Frank","year":"2008","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1213\/ANE.0000000000001683","article-title":"Trends in tramadol: pharmacology, metabolism, and misuse","volume":"124","author":"Miotto","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0016","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0022-3565(25)39454-1","article-title":"Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol","volume":"267","author":"Raffa","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0017","series-title":"Medical Genetics Summaries","first-page":"397","article-title":"Tramadol therapy and CYP2D6 genotype","author":"Dean","year":"2012"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0018","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical pharmacology of tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0019","unstructured":"Food and Drug Administration (FDA). ULTRAM (tramadol hydrochloride) Tablets Full Prescribing Information. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020281s032s033lbl.pdf. 2009. pp 1\u201322."},{"key":"10.1016\/j.amjmed.2018.04.025_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00210-003-0832-2","article-title":"Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry","volume":"369","author":"Zanger","year":"2004","journal-title":"Naunyn Schmiedeberg Arch Pharmacol"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0021","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejfs.2011.04.016","article-title":"Some medicolegal aspects concerning tramadol abuse: the new Middle East youth plague 2010. An Egyptian overview","volume":"1","author":"Fawzi","year":"2011","journal-title":"Egypt J Forensic Sci"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0022","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1345\/aph.1Q748","article-title":"Avoiding serotonin syndrome: the nature of the interaction between tramadol and selective serotonin reuptake inhibitors","volume":"46","author":"Nelson","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0023","first-page":"533","article-title":"Serotonin syndrome","volume":"13","author":"Volpi-Abadie","year":"2013","journal-title":"Ochsner J"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0024","author":"Boyer"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0025","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1742-7843.2008.00276.x","article-title":"Tramadol-induced seizurogenic effect: a possible role of opioid-dependent gamma-aminobutyric acid inhibitory pathway","volume":"103","author":"Rehni","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0026","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/psb.1388","article-title":"Recognition and management of serotonin syndrome","volume":"26","author":"Kenicer","year":"2015","journal-title":"Prescriber"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0027","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1345\/aph.1D344","article-title":"Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine","volume":"38","author":"Houlihan","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0028","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0897190013504957","article-title":"Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants?","volume":"27","author":"Park","year":"2014","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0029","doi-asserted-by":"crossref","first-page":"g1626","DOI":"10.1136\/bmj.g1626","article-title":"Serotonin syndrome","volume":"348","author":"Buckley","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0030","first-page":"273","article-title":"Serotonin syndrome associated with tramadol","volume":"11","author":"Takeshita","year":"2009","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0031","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/15563651003709427","article-title":"Tramadol overdose as a cause of serotonin syndrome: a case series","volume":"48","author":"Tashakori","year":"2010","journal-title":"Clin Toxicol (Philadelphia)"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0032","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0033","first-page":"1139","article-title":"Prevention, recognition, and management of serotonin syndrome","volume":"81","author":"Ables","year":"2010","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0034","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1176\/ajp.154.6.884a","article-title":"Cyproheptadine: a potent in vivo serotonin antagonist","volume":"154","author":"Kapur","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0736-4679(98)00057-2","article-title":"Treatment of the serotonin syndrome with cyproheptadine","volume":"16","author":"Graudins","year":"1998","journal-title":"J Emerg Med"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0036","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1345\/aph.1E577","article-title":"Tramadol exposures reported to statewide poison control system","volume":"39","author":"Marquardt","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0037","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/15563659709043367","article-title":"Prospective multicenter evaluation of tramadol exposure","volume":"35","author":"Spiller","year":"1997","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0038","first-page":"484","article-title":"Tramadol induced seizure: A 3-year study","volume":"3","author":"Boostani","year":"2012","journal-title":"Caspian J Intern Med"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0039","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1592\/phco.20.19.1423.34854","article-title":"Tramadol and seizures: a surveillance study in a managed care population","volume":"20","author":"Gardner","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/j.1875-9114.1998.tb03123.x","article-title":"The risk of seizures associated with tramadol","volume":"18","author":"Jick","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"suppl 1","key":"10.1016\/j.amjmed.2018.04.025_bib0041","first-page":"S34","article-title":"Tramadol-induced seizures and trauma","volume":"16","author":"Farajidana","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0042","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.1997.03550200037026","article-title":"Seizures reported with tramadol","volume":"278","author":"Kahn","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0043","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03161089","article-title":"Dose-independent occurrence of seizure with tramadol","volume":"5","author":"Talaie","year":"2009","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0044","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF03161089","article-title":"Dose-independent occurrence of seizure with tramadol","volume":"5","author":"Talaie","year":"2009","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s13181-011-0168-0","article-title":"Factors related to seizure in tramadol poisoning and its blood concentration","volume":"7","author":"Taghaddosinejad","year":"2011","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0046","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1592\/phco.20.7.629.35174","article-title":"Incidence of first-time idiopathic seizures in users of tramadol","volume":"20","author":"Gasse","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0047","unstructured":"National Institute on Drug Abuse Pain and Opiophobia. Research Report Series\u2014Prescription Drugs: Abuse and Addiction."},{"key":"10.1016\/j.amjmed.2018.04.025_bib0048","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/1556365050014418","article-title":"Seizures associated with intoxication and abuse of tramadol","volume":"44","author":"Jovanovic-Cupic","year":"2006","journal-title":"Clin Toxicol (Philadelphia)"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0049","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0960327108090270","article-title":"Tramadol intoxication: a review of 114 cases","volume":"27","author":"Shadnia","year":"2008","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.amjmed.2018.04.025_bib0050","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1742-7843.2012.00874.x","article-title":"Recurrent seizures in tramadol intoxication: implications for therapy based on 100 patients","volume":"111","author":"Shadnia","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934318304029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934318304029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:16:45Z","timestamp":1757582205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934318304029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0002934318304029"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.04.025","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}